D&D Pharmatech is showing strong momentum, recording double-digit gains during trading on the 7th. Trading volume and value have surged, drawing investor attention.

As of 11:43 a.m. on the day, D&D Pharmatech traded at 84,900 won, up 9,000 won (11.86%) from the previous trading day. During the session, it rose to as high as 91,900 won in an attempt to break the 90,000-won threshold, while the intraday low was 72,600 won and the opening price was 73,000 won.

Trading volume exceeded approximately 3.06 million shares, and the trading value reached about 267 billion won. The market capitalization stood at approximately 3.7707 trillion won, with the foreign ownership rate at 5.81%.

Amid recently expanding volatility, buying interest has flowed in, driving the stock price sharply higher. During the session, the gap with the 52-week high of 116,600 won narrowed, but some profit-taking sell orders emerged near the high, widening the price fluctuation range.

In the biotech sector, investor sentiment is heavily influenced by new drug development progress, clinical trial results, technology transfers (license-out), and R&D achievements. Accordingly, analysts note that individual stocks may also experience increased short-term volatility depending on supply and demand changes and overall market conditions.

In the market, D&D Pharmatech's strength continues alongside rising trading volume, heightening investor interest. However, some opinions suggest that a cautious approach is necessary, as intraday stock price volatility may widen depending on supply and demand dynamics and investor sentiment.

[This article was written with the assistance of AI. AI was utilized in the writing process, and the final content was reviewed based on factual accuracy. This article does not constitute investment advice for any specific stock, and the responsibility for investment decisions lies solely with the investor.]